Intranasal immunization with Ag85B peptide 25 displayed on Lactococcus lactis using the PilVax platform induces antigen‐specific B‐ and T‐cell responses-Reference-Cited by-同舟云学术

Intranasal immunization with Ag85B peptide 25 displayed on Lactococcus lactis using the PilVax platform induces antigen‐specific B‐ and T‐cell responses

Published:2021-05-20 Issue:7 Volume:99 Page:767-781
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol. Cell Biol.

Author:

Blanchett Samuel¹,Tsai Catherine JY¹²,Sandford Sarah³,Loh Jacelyn MS¹²,Huang Lucy³,Kirman Joanna R²³^ORCID,Proft Thomas¹²^ORCID

Affiliation:

1. Department of Molecular Medicine and Pathology School of Medical Sciences The University of Auckland Auckland New Zealand

2. Maurice Wilkins Centre for Biomolecular Discoveries The University of Auckland Auckland New Zealand

3. Department of Microbiology & Immunology University of Otago Dunedin New Zealand

Funder

University of Auckland

Auckland Medical Research Foundation

Royal Society Te Apārangi

National Heart Foundation of New Zealand

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imcb.12462

Reference45 articles.

1. WHO.Global tuberculosis report 2019.

2. Tuberculosis

3. Centers for Disease Control and Prevention.The Costly Burden of Drug‐Resistant TB Disease in the U.S.: Centers for Disease Control and Prevention (CDC);2018.

4. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree

5. Nasal associated lymphoid tissue (NALT) contributes little to protection against aerosol challenge with Mycobacterium tuberculosis after immunisation with a recombinant adenoviral vaccine

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Group A Streptococcus Pili—Roles in Pathogenesis and Potential for Vaccine Development;Microorganisms;2024-03-11

2. Mucosal vaccination: onward and upward;Expert Review of Vaccines;2023-10-17

3. Expanding strain coverage of a group A Streptococcus pilus–expressing Lactococcus lactis mucosal vaccine;Immunology & Cell Biology;2023-04-24

4. Oral and intranasal immunization with food-grade recombinant Lactococcus lactis expressing high conserved region of SARS-CoV-2 spike protein triggers mice’s immunity responses;Vaccine: X;2023-04

5. COVID-19 and Tuberculosis: Two Knives in a Sheath;Coronaviruses;2022-10